Corrigendum

No authors listed

Published Erratum

No authors listed. Aliment Pharmacol Ther. 2020 Nov.

. 2020 Nov;52(9):1533.

doi: 10.1111/apt.16094.

No abstract available

Erratum for

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study.
Amiot A, Filippi J, Abitbol V, Cadiot G, Laharie D, Serrero M, Altwegg R, Bouhnik Y, Peyrin-Biroulet L, Gilletta C, Roblin X, Pineton de Chambrun G, Vuitton L, Bourrier A, Nancey S, Gornet JM, Nahon S, Bouguen G, Viennot S, Pariente B, Fumery M; UC-USK-GETAID Study Group. Amiot A, et al. Aliment Pharmacol Ther. 2020 Jun;51(11):1039-1046. doi: 10.1111/apt.15717. Epub 2020 Apr 14. Aliment Pharmacol Ther. 2020. PMID: 32291786

1. Amiot A, Filippi J, Abitbol V, et al.; UC-USK-GETAID Study Group. Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study. Aliment Pharmacol Ther. 2020;51:1039-1046.